The primary outcome of the study will be a composite of progression to severe disease (PaO2/FiO2 ratio less than 100mmHg) any time within 28 days of enrolment or all cause mortality at 28 days. If progression to severe disease or all cause mortality could be prevented in the 28 days post-enrolment; the primary outcome will be considered as â??goodâ?? and if not it will be considered â??poorâ??.Timepoint: The primary outcome of the study will be a composite of progression to severe disease (PaO2/FiO2 ratio less than 100mmHg) any time within 28 days of enrolment or all cause mortality at 28 days. If progression to severe disease or all cause mortality could be prevented in the 28 days post-enrolment; the primary outcome will be considered as â??goodâ?? and if not it will be considered â??poorâ??.

The primary outcome of the study will be a composite of progression to severe disease (PaO2/FiO2 ratio less than 100mmHg) any time within 28 days of enrolment or all cause mortality at 28 days. If progression to severe disease or all cause mortality could be prevented in the 28 days post-enrolment; the primary outcome will be considered as â??goodâ?? and if not it will be considered â??poorâ??.Timepoint: The primary outcome of the study will be a composite of progression to severe disease (PaO2/FiO2 ratio less than 100mmHg) any time within 28 days of enrolment or all cause mortality at 28 days. If progression to severe disease or all cause mortality could be prevented in the 28 days post-enrolment; the primary outcome will be considered as â??goodâ?? and if not it will be considered â??poorâ??.

N/A

N/A

The primary outcome of the study will be a composite of progression to severe disease (PaO2/FiO2 ratio less than 100mmHg) any time within 28 days of enrolment or all cause mortality at 28 days. If progression to severe disease or all cause mortality could be prevented in the 28 days post-enrolment; the primary outcome will be considered as â??goodâ?? and if not it will be considered â??poorâ??.Timepoint: The primary outcome of the study will be a composite of progression to severe disease (PaO2/FiO2 ratio less than 100mmHg) any time within 28 days of enrolment or all cause mortality at 28 days. If progression to severe disease or all cause mortality could be prevented in the 28 days post-enrolment; the primary outcome will be considered as â??goodâ?? and if not it will be considered â??poorâ??.

The primary outcome of the study will be a composite of progression to severe disease (PaO2/FiO2 ratio less than 100mmHg) any time within 28 days of enrolment or all cause mortality at 28 days. If progression to severe disease or all cause mortality could be prevented in the 28 days post-enrolment; the primary outcome will be considered as â??goodâ?? and if not it will be considered â??poorâ??.Timepoint: The primary outcome of the study will be a composite of progression to severe disease (PaO2/FiO2 ratio less than 100mmHg) any time within 28 days of enrolment or all cause mortality at 28 days. If progression to severe disease or all cause mortality could be prevented in the 28 days post-enrolment; the primary outcome will be considered as â??goodâ?? and if not it will be considered â??poorâ??.